{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:18:35Z","timestamp":1770884315550,"version":"3.50.1"},"reference-count":54,"publisher":"Bentham Science Publishers Ltd.","issue":"8","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81774402"],"award-info":[{"award-number":["81774402"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jinan 20 Universities funding project","award":["2020GXRC005"],"award-info":[{"award-number":["2020GXRC005"]}]},{"name":"Shandong University of Traditional Chinese Medicine","award":["22202110"],"award-info":[{"award-number":["22202110"]}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCHTS"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Irritable bowel syndrome (IBS) is the most common gastrointestinal disease\nworldwide, with diarrhea-predominant irritable bowel syndrome (IBS-D) being the prevalent\nsubtype. However, its pathogenesis remains unclear. Research has increasingly focused on identifying\ngenetic factors in the mechanisms underlying IBS.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>We aimed to explore key gene nodes and potential microRNA-mRNA regulatory pairs of\nIBS-D using bioinformatics methods.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>We downloaded the GSE36701 microarray dataset from the Gene Expression Omnibus\ndatabase and obtained 1358 differentially expressed mRNAs by analyzing mRNA profiles using the\nGEO2R analysis tool. Based on our previous study, we used TargetScan, miTarBase, and miRDB to\npredict the downstream genes of three known microRNAs (hsa-let-7b-5p, hsa-miR-19b-3p, and hsamiR-\n20a-5p), and the microRNA-mRNA regulatory network was visualized using Cytoscape.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>A total of 795 downstream target genes were found in TargetScan, miRTarBase, and\nmiRDB databases, and 50 candidate genes were obtained. The Metascape and STRING databases\nwere used to perform enrichment analysis and construct a protein-protein interaction network of\ncandidate genes. Finally, we constructed a network of 3 microRNAs and 50 candidate mRNAs,\namong which 28 negative relation ship pairs and 5 key axes (hsa-miR-20a-5p\/VEGFA, hsa-let-7b-\n5p\/MSN, hsa-let-7b-5p \/PPP1R16B, hsa-19b-3p\/ITGA2, and hsa-19b-3p\/PIK3R3) were identified.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>We report five novel microRNA-mRNA regulatory axes in IBS-D pathogenesis and\nspeculated that PIK3R3, negatively regulated by hsa-miR-19b-3p, may regulate NF-\u03baB production\nthrough the PI3K\/Akt pathway, which accounts for the occurrence of clinical symptoms in IBS-D\npatients. Our findings may offer key biomarkers for IBS-D diagnosis and treatment.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1386207326666230109143325","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T05:45:03Z","timestamp":1673329503000},"page":"1618-1628","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Identification of Potential MicroRNA-MRNA Regulatory Relationship\nPairs in Irritable Bowel Syndrome with Diarrhea"],"prefix":"10.2174","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7062-2698","authenticated-orcid":true,"given":"Wenli","family":"Yan","sequence":"first","affiliation":[{"name":"College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6316-9282","authenticated-orcid":true,"given":"Zunqi","family":"Kan","sequence":"additional","affiliation":[{"name":"College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4160-7752","authenticated-orcid":true,"given":"Zhaofeng","family":"Li","sequence":"additional","affiliation":[{"name":"Department\nof Acupuncture-Moxibustion and Tuina, Shandong University of Traditional Chinese Medicine, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1578-2220","authenticated-orcid":true,"given":"Yuxia","family":"Ma","sequence":"additional","affiliation":[{"name":"Department\nof Acupuncture-Moxibustion and Tuina, Shandong University of Traditional Chinese Medicine, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3763-7553","authenticated-orcid":true,"given":"Dongqing","family":"Du","sequence":"additional","affiliation":[{"name":"Department\nof Acupuncture-Moxibustion and Tuina, Shandong University of Traditional Chinese Medicine, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.3389\/fmicb.2019.01136","volume":"10","author":"Chong P.P.","year":"2019","unstructured":"Chong P.P.; Chin V.K.; Looi C.Y.; Wong W.F.; Madhavan P.; Yong V.C.; The microbiome and irritable bowel syndrome-A review on the pathophysiology, current research and future therapy. Front Microbiol 2019,10,1136","journal-title":"Front Microbiol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"153589","DOI":"10.1016\/j.phymed.2021.153589","volume":"88","author":"Elbadawi M.","year":"2021","unstructured":"Elbadawi M.; Ammar R.M.; Aziz-Kalbhenn H.; Rabini S.; Klauck S.M.; Dawood M.; Saeed M.E.M.; Kampf C.J.; Efferth T.; Anti-inflammatory and tight junction protective activity of the herbal preparation STW 5-II on mouse intestinal organoids. Phytomedicine 2021,88,153589","journal-title":"Phytomedicine"},{"key":"ref=3","author":"Mearin F.","unstructured":"Mearin F.; Lacy B.E.; Chang L.; Chey W.D.; Lembo A.J.; Simren M.; Spiller R.; Bowel disorders.Gastroenterology, 2016.S0016-5085(16)00222-5]"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1136\/gutjnl-2015-311240","volume":"66","author":"Sperber A.D.","year":"2017","unstructured":"Sperber A.D.; Dumitrascu D.; Fukudo S.; Gerson C.; Ghoshal U.C.; Gwee K.A.; Hungin A.P.S.; Kang J.Y.; Minhu C.; Schmulson M.; Bolotin A.; Friger M.; Freud T.; Whitehead W.; The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: A Rome Foundation working team literature review. Gut 2017,66(6),1075-1082","journal-title":"Gut"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"729346","DOI":"10.3389\/fcimb.2021.729346","volume":"11","author":"Xiao L.","year":"2021","unstructured":"Xiao L.; Liu Q.; Luo M.; Xiong L.; Gut microbiota-derived metabolites in irritable bowel syndrome. Front Cell Infect Microbiol 2021,11,729346-729346","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2020067","DOI":"10.1080\/19490976.2021.2020067","volume":"14","author":"Singh P.","year":"2022","unstructured":"Singh P.; Alm E.J.; Kelley J.M.; Cheng V.; Smith M.; Kassam Z.; Nee J.; Iturrino J.; Lembo A.; Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D. Gut Microbes 2022,14(1),2020067","journal-title":"Gut Microbes"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e01255","DOI":"10.1128\/Spectrum.01255-21","volume":"9","author":"Zhu X.","year":"2021","unstructured":"Zhu X.; Hong G.; Li Y.; Yang P.; Cheng M.; Zhang L.; Li Y.; Ji L.; Li G.; Chen C.; Zhong C.; Jin Y.; Yang M.; Xiong H.; Qian W.; Ding Z.; Ning K.; Hou X.; Understanding of the site-specific microbial patterns towards accurate identification for patients with diarrhea-predominant irritable bowel syndrome. Microbiol Spectr 2021,9(3),e01255-e21","journal-title":"Microbiol Spectr"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S2468-1253(16)30023-1","volume":"1","author":"Holtmann G.J.","year":"2016","unstructured":"Holtmann G.J.; Ford A.C.; Talley N.J.; Pathophysiology of irritable bowel syndrome. Lancet Gastroenterol Hepatol 2016,1(2),133-146","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/S0140-6736(20)31548-8","volume":"396","author":"Ford A.C.","year":"2020","unstructured":"Ford A.C.; Sperber A.D.; Corsetti M.; Camilleri M.; Irritable bowel syndrome. Lancet 2020,396(10263),1675-1688","journal-title":"Lancet"},{"key":"ref=10a","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.3390\/nu13072469","volume":"13","author":"Prospero L.","year":"2021","unstructured":"Prospero L.; Riezzo G.; Linsalata M.; Orlando A.; D\u2019Attoma B.; Russo F.; Psychological and gastrointestinal symptoms of patients with irritable bowel syndrome undergoing a low-FODMAP diet: The role of the intestinal barrier. Nutrients 2021,13(7),2469","journal-title":"Nutrients"},{"key":"ref=10b","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2147\/JIR.S174982","volume":"11","year":"2018","unstructured":"The role of inflammation in irritable bowel syndrome (IBS). J Inflamm Res 2018,11,345-349","journal-title":"J Inflamm Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nrgastro.2011.83","volume":"8","author":"Zhou Q.","year":"2011","unstructured":"Zhou Q.; Verne G.N.; New insights into visceral hypersensitivity-Clinical implications in IBS. Nat Rev Gastroenterol Hepatol 2011,8(6),349-355","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3748\/wjg.v23.i1.93","volume":"23","author":"Ren H.X.","year":"2017","unstructured":"Ren H.X.; Zhang F.C.; Luo H.S.; Zhang G.; Liang L.X.; Role of mast cell-miR-490-5p in irritable bowel syndrome. World J Gastroenterol 2017,23(1),93-102","journal-title":"World J Gastroenterol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nrd3179","volume":"9","author":"Garzon R.","year":"2010","unstructured":"Garzon R.; Marcucci G.; Croce C.M.; Targeting microRNAs in cancer: Rationale, strategies and challenges. Nat Rev Drug Discov 2010,9(10),775-789","journal-title":"Nat Rev Drug Discov"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3892\/etm.2020.9284","volume":"20","author":"Zhu H.","year":"2020","unstructured":"Zhu H.; Xiao X.; Shi Y.; Wu Y.; Huang Y.; Li D.; Xiong F.; He G.; Chai Y.; Tang H.; Inhibition of miRNA 29a regulates intestinal barrier function in diarrhea predominant irritable bowel syndrome by upregulating ZO 1 and CLDN1. Exp Ther Med 2020,20(6),155","journal-title":"Exp Ther Med"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1053\/j.gastro.2014.09.037","volume":"148","author":"Zhou Q.","year":"2015","unstructured":"Zhou Q.; Costinean S.; Croce C.M.; Brasier A.R.; Merwat S.; Larson S.A.; Basra S.; Verne G.N.; MicroRNA 29 targets nuclear factor-\u03baB-repressing factor and Claudin 1 to increase intestinal permeability. Gastroenterology 2015,148(1),158-169.e8","journal-title":"Gastroenterology"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1053\/j.gastro.2021.02.040","volume":"160","author":"Mahurkar-Joshi S.","year":"2021","unstructured":"Mahurkar-Joshi S.; Rankin C.R.; Videlock E.J.; Soroosh A.; Verma A.; Khandadash A.; Iliopoulos D.; Pothoulakis C.; Mayer E.A.; Chang L.; The colonic mucosal MicroRNAs, MicroRNA-219a-5p, and MicroRNA-338-3p are downregulated in irritable bowel syndrome and are associated with barrier function and MAPK signaling. Gastroenterology 2021,160(7),2409-2422.e19","journal-title":"Gastroenterology"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1136\/gutjnl-2013-306464","volume":"65","author":"Zhou Q.","year":"2016","unstructured":"Zhou Q.; Yang L.; Larson S.; Basra S.; Merwat S.; Tan A.; Croce C.; Verne G.N.; Decreased miR-199 augments visceral pain in patients with IBS through translational upregulation of TRPV1. Gut 2016,65(5),797-805","journal-title":"Gut"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"14680","DOI":"10.1038\/s41598-017-13982-0","volume":"7","author":"Wohlfarth C.","year":"2017","unstructured":"Wohlfarth C.; Schmitteckert S.; H\u00e4rtle J.D.; Houghton L.A.; Dweep H.; Fortea M.; Assadi G.; Braun A.; Mederer T.; P\u00f6hner S.; Becker P.P.; Fischer C.; Granzow M.; M\u00f6nnikes H.; Mayer E.A.; Sayuk G.; Boeckxstaens G.; Wouters M.M.; Simr\u00e9n M.; Lindberg G.; Ohlsson B.; Schmidt P.T.; Dlugosz A.; Agreus L.; Andreasson A.; D\u2019Amato M.; Burwinkel B.; Bermejo J.L.; R\u00f6th R.; Lasitschka F.; Vicario M.; Metzger M.; Santos J.; Rappold G.A.; Martinez C.; Niesler B.; miR-16 and miR-103 impact 5-HT4 receptor signalling and correlate with symptom profile in irritable bowel syndrome. Sci Rep 2017,7(1),14680","journal-title":"Sci Rep"},{"key":"ref=19","first-page":"2688","volume":"36","author":"Yue Z.H.O.U.","year":"2021","unstructured":"Yue Z.H.O.U.; Regulation effects of microRNA expression in diarrhea-predominant irritable bowel syndrome patients treated with herb-partitioned moxibustion on the navel. Zhonghua Zhongyiyao Zazhi 2021,36(5),2688-2693","journal-title":"Zhonghua Zhongyiyao Zazhi"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","volume":"5","author":"Gentleman R.C.","year":"2004","unstructured":"Gentleman R.C.; Carey V.J.; Bates D.M.; Bolstad B.; Dettling M.; Dudoit S.; Ellis B.; Gautier L.; Ge Y.; Gentry J.; Hornik K.; Hothorn T.; Huber W.; Iacus S.; Irizarry R.; Leisch F.; Li C.; Maechler M.; Rossini A.J.; Sawitzki G.; Smith C.; Smyth G.; Tierney L.; Yang J.Y.H.; Zhang J.; Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol 2004,5(10),R80","journal-title":"Genome Biol"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"Barrett T.","year":"2013","unstructured":"Barrett T.; Wilhite S.E.; Ledoux P.; Evangelista C.; Kim I.F.; Tomashevsky M.; Marshall K.A.; Phillippy K.H.; Sherman P.M.; Holko M.; Yefanov A.; Lee H.; Zhang N.; Robertson C.L.; Serova N.; Davis S.; Soboleva A.; NCBI GEO: Archive for functional genomics data sets - update. Nucleic Acids Res 2013,41(Database issue),D991-D995","journal-title":"Nucleic Acids Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12967-020-02698-x","volume":"19","author":"Zhao X.","year":"2021","unstructured":"Zhao X.; Zhang L.; Wang J.; Zhang M.; Song Z.; Ni B.; You Y.; Identification of key biomarkers and immune infiltration in systemic lupus erythematosus by integrated bioinformatics analysis. J Transl Med 2021,19(1),35","journal-title":"J Transl Med"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1017\/S0007114521001215","volume":"127","author":"Benardout M.","year":"2022","unstructured":"Benardout M.; Le Gresley A.; ElShaer A.; Wren S.P.; Fructose malabsorption: Causes, diagnosis and treatment. Br J Nutr 2022,127(4),481-489","journal-title":"Br J Nutr"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1172\/JCI130976","volume":"130","author":"Zhao L.","year":"2019","unstructured":"Zhao L.; Yang W.; Chen Y.; Huang F.; Lu L.; Lin C.; Huang T.; Ning Z.; Zhai L.; Zhong L.L.D.; Lam W.; Yang Z.; Zhang X.; Cheng C.; Han L.; Qiu Q.; Shang X.; Huang R.; Xiao H.; Ren Z.; Chen D.; Sun S.; El-Nezami H.; Cai Z.; Lu A.; Fang X.; Jia W.; Bian Z.; A Clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome. J Clin Invest 2019,130(1),438-450","journal-title":"J Clin Invest"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrgastro.2014.127","volume":"11","author":"Sood R.","year":"2014","unstructured":"Sood R.; Law G.R.; Ford A.C.; Diagnosis of IBS: Symptoms, symptom-based criteria, biomarkers or \u2018psychomarkers\u2019? Nat Rev Gastroenterol Hepatol 2014,11(11),683-691","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.cgh.2020.09.043","volume":"20","author":"Shah E.D.","year":"2022","unstructured":"Shah E.D.; Salwen-Deremer J.K.; Gibson P.R.; Muir J.G.; Eswaran S.; Chey W.D.; Comparing costs and outcomes of treatments for irritable bowel syndrome with diarrhea: Cost-benefit analysis. Clin Gastroenterol Hepatol 2022,20(1),136-144.e31","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"47175","DOI":"10.18632\/oncotarget.17565","volume":"8","author":"Chao G.","year":"2017","unstructured":"Chao G.; Zhang S.; Aquaporins 1, 3 and 8 expression in irritable bowel syndrome rats\u2019 colon via NF-\u03baB pathway. Oncotarget 2017,8(29),47175-47183","journal-title":"Oncotarget"},{"key":"ref=28a","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000506306","volume":"102","author":"Kalli T.","year":"2021","unstructured":"Kalli T.; Koutouratsas T.; Karamanolis G.; Gazouli M.; Ghrelin gene polymorphisms in irritable bowel syndrome. Digestion 2021,102(3),313-318","journal-title":"Digestion"},{"key":"ref=28b","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1053\/gast.2001.27995","volume":"121","author":"Levy R.L.","year":"2001","unstructured":"Levy R.L.; Jones K.R.; Whitehead W.E.; Feld S.I.; Talley N.J.; Corey L.A.; Irritable bowel syndrome in twins: Heredity and social learning both contribute to etiology. Gastroenterology 2001,121(4),799-804","journal-title":"Gastroenterology"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1093\/hmg\/ddn195","volume":"17","author":"Kapeller J.","year":"2008","unstructured":"Kapeller J.; Houghton L.A.; M\u00f6nnikes H.; Walstab J.; M\u00f6ller D.; B\u00f6nisch H.; Burwinkel B.; Autschbach F.; Funke B.; Lasitschka F.; Gassler N.; Fischer C.; Whorwell P.J.; Atkinson W.; Fell C.; B\u00fcchner K.J.; Schmidtmann M.; van der Voort I.; Wisser A.S.; Berg T.; Rappold G.; Niesler B.; First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome. Hum Mol Genet 2008,17(19),2967-2977","journal-title":"Hum Mol Genet"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/09645284211027892","volume":"40","author":"Guo J.","year":"2022","unstructured":"Guo J.; Lu G.; Chen L.; Geng H.; Wu X.; Chen H.; Li Y.; Yuan M.; Sun J.; Pei L.; Regulation of serum microRNA expression by acupuncture in patients with diarrhea-predominant irritable bowel syndrome. Acupunct Med 2022,40(1),34-42","journal-title":"Acupunct Med"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1537.1","DOI":"10.1136\/gutjnl-2016-311477]","volume":"66","author":"Mart\u00ednez C.","year":"2017","unstructured":"Mart\u00ednez C.; Rodi\u00f1o-Janeiro B.K.; Lobo B.; Stanifer M.L.; Klaus B.; Granzow M.; Gonz\u00e1lez-Castro A.M.; Salvo-Romero E.; Alonso-Cotoner C.; Pigrau M.; Roeth R.; Rappold G.; Huber W.; Gonz\u00e1lez-Silos R.; Lorenzo J.; de Torres I.; Azpiroz F.; Boulant S.; Vicario M.; Niesler B.; Santos J.; miR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea. Gut, 2017,66(9),1537.1-1538"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/ibd.21267","volume":"16","author":"Wu F.","year":"2010","unstructured":"Wu F.; Zhang S.; Dassopoulos T.; Harris M.L.; Bayless T.M.; Meltzer S.J.; Brant S.R.; Kwon J.H.; Identification of microRNAs associated with ileal and colonic Crohn\u02bcs disease. Inflamm Bowel Dis 2010,16(10),1729-1738","journal-title":"Inflamm Bowel Dis"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S0002-9270(01)04037-0","volume":"97","author":"Simr\u00e9n M.","year":"2002","unstructured":"Simr\u00e9n M.; Axelsson J.; Gillberg R.; Abrahamsson H.; Svedlund J.; Bj\u00f6rnsson E.S.; Quality of life in inflammatory bowel disease in remission: The impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 2002,97(2),389-396","journal-title":"Am J Gastroenterol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1023\/B:DDAS.0000020506.84248.f9","volume":"49","author":"Minderhoud I.M.","year":"2004","unstructured":"Minderhoud I.M.; Oldenburg B.; Wismeijer J.A.; Van Berge Henegouwen G.P.; Smout A.J.P.M.; IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci 2004,49(3),469-474","journal-title":"Dig Dis Sci"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1038\/ajg.2010.156","volume":"105","author":"Keohane J.","year":"2010","unstructured":"Keohane J.; O\u2019Mahony C.; O\u2019Mahony L.; O\u2019Mahony S.; Quigley E.M.; Shanahan F.; Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: A real association or reflection of occult inflammation? Am J Gastroenterol 2010,105(8),1788","journal-title":"Am J Gastroenterol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/iub.2270","volume":"72","author":"Fei L.","year":"2020","unstructured":"Fei L.; Wang Y.; microRNA\u2010495 reduces visceral sensitivity in mice with diarrhea\u2010predominant irritable bowel syndrome through suppression of the PI3K\/AKT signaling pathway via PKIB. IUBMB Life 2020,72(7),1468-1480","journal-title":"IUBMB Life"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"13644","DOI":"10.1096\/fj.201901192R","volume":"33","author":"Zhang L.","year":"2019","unstructured":"Zhang L.; Wang R.; Bai T.; Xiang X.; Qian W.; Song J.; Hou X.; EphrinB2\/ephB2\u2010mediated myenteric synaptic plasticity: Mechanisms underlying the persistent muscle hypercontractility and pain in postinfectious IBS. FASEB J 2019,33(12),13644-13659","journal-title":"FASEB J"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/3912931","volume":"2020","author":"Li B.","year":"2020","unstructured":"Li B.; Luo X.F.; Liu S.W.; Zhao N.; Li H.N.; Zhang W.; Chen Y.Y.; Bao A.; Wang J.G.; Wang Q.S.; Abdominal massage reduces visceral hypersensitivity via regulating GDNF and PI3K\/AKT signal pathway in a rat model of irritable bowel syndrome. Evid Based Complement Alternat Med 2020,2020,1-10","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1755-8794-5-34","volume":"5","author":"Zhou J.","year":"2012","unstructured":"Zhou J.; Chen G.B.; Tang Y.C.; Sinha R.A.; Wu Y.; Yap C.S.; Wang G.; Hu J.; Xia X.; Tan P.; Goh L.K.; Yen P.M.; Genetic and bioinformatic analyses of the expression and function of PI3K regulatory subunit PIK3R3 in an Asian patient gastric cancer library. BMC Med Genomics 2012,5(1),34","journal-title":"BMC Med Genomics"},{"key":"ref=40a","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cyto.2017.05.005","volume":"93","author":"Choghakhori R.","year":"2017","unstructured":"Choghakhori R.; Abbasnezhad A.; Hasanvand A.; Amani R.; Inflammatory cytokines and oxidative stress biomarkers in irritable bowel syndrome: Association with digestive symptoms and quality of life. Cytokine 2017,93,34-43","journal-title":"Cytokine"},{"key":"ref=40b","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10787-021-00907-7","volume":"30","author":"Khodabakhsh P.","year":"2022","unstructured":"Khodabakhsh P.; Khoie N.; Dehpour A.R.; Abdollahi A.; Ghazi-Khansari M.; Shafaroodii H.; Montelukast suppresses the development of irritable bowel syndrome phenotype possibly through modulating NF-\u03baB signaling in an experimental model. Inflammopharmacology 2022,30(1),313-325","journal-title":"Inflammopharmacology"},{"key":"ref=40c","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12876-021-01626-7","volume":"21","author":"Lin Z.","year":"2021","unstructured":"Lin Z.; Wang Y.; Lin S.; Liu D.; Mo G.; Zhang H.; Dou Y.; Identification of potential biomarkers for abdominal pain in IBS patients by bioinformatics approach. BMC Gastroenterol 2021,21(1),48","journal-title":"BMC Gastroenterol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"113957","DOI":"10.18632\/oncotarget.23045","volume":"8","author":"He X.","year":"2017","unstructured":"He X.; Cui L.H.; Wang X.H.; Yan Z.H.; Li C.; Gong S.D.; Zheng Y.; Luo Z.; Wang Y.; Modulation of inflammation by toll-like receptor 4\/nuclear factor-kappa B in diarrhea-predominant irritable bowel syndrome. Oncotarget 2017,8(69),113957-113965","journal-title":"Oncotarget"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.3389\/fphys.2018.01942","volume":"9","author":"Bhat A.A.","year":"2019","unstructured":"Bhat A.A.; Uppada S.; Achkar I.W.; Hashem S.; Yadav S.K.; Shanmugakonar M.; Al-Naemi H.A.; Haris M.; Uddin S.; Tight junction proteins and signaling pathways in cancer and inflammation: A functional crosstalk. Front Physiol 2019,9,1942","journal-title":"Front Physiol"},{"key":"ref=43a","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/13880209.2021.2010775","volume":"60","author":"Luo L.","year":"2022","unstructured":"Luo L.; Liang H.; Liu L.; Myristicin regulates proliferation and apoptosis in oxidized low-density lipoprotein-stimulated human vascular smooth muscle cells and human umbilical vein endothelial cells by regulating the PI3K\/Akt\/NF-\u03baB signalling pathway. Pharm Biol 2022,60(1),56-64","journal-title":"Pharm Biol"},{"key":"ref=43b","doi-asserted-by":"crossref","first-page":"105519","DOI":"10.1016\/j.bioorg.2021.105519","volume":"119","author":"Wei X.","year":"2022","unstructured":"Wei X.; Zhou R.; Xhen Y.; Ma G.; Yang Y.; Lu C.; Xu W.; Hu W.; Systemic pharmacological verification of Baixianfeng decoction regulating TNF-PI3K-Akt-NF-\u03baB pathway in treating rheumatoid arthritis. Bioorg Chem 2022,119,105519","journal-title":"Bioorg Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.intimp.2011.12.001","volume":"12","author":"Qi S.","year":"2012","unstructured":"Qi S.; Xin Y.; Guo Y.; Diao Y.; Kou X.; Luo L.; Yin Z.; Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K\/Akt\/NF-\u03baB signaling pathways. Int Immunopharmacol 2012,12(1),278-287","journal-title":"Int Immunopharmacol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41538-018-0022-8","volume":"2","author":"Shao D.","year":"2018","unstructured":"Shao D.; Lian Z.; Di Y.; Zhang L.; Rajoka M.; Zhang Y.; Kong J.; Jiang C.; Shi J.; Dietary compounds have potential in controlling atherosclerosis by modulating macrophage cholesterol metabolism and inflammation via miRNA. NPJ Sci Food 2018,2(1),13","journal-title":"NPJ Sci Food"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"8751","DOI":"10.3390\/ijms23158751","volume":"23","author":"Krishnachaitanya S.S.","year":"2022","unstructured":"Krishnachaitanya S.S.; Liu M.; Fujise K.; Li Q.; MicroRNAs in inflammatory bowel disease and its complications. Int J Mol Sci 2022,23(15),8751","journal-title":"Int J Mol Sci"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1136\/gutjnl-2014-307891","volume":"64","author":"Kalla R.","year":"2015","unstructured":"Kalla R.; Ventham N.T.; Kennedy N.A.; Quintana J.F.; Nimmo E.R.; Buck A.H.; Satsangi J.; MicroRNAs: New players in IBD. Gut 2015,64(3),504-513","journal-title":"Gut"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"5565","DOI":"10.3390\/cancers13215565","volume":"13","author":"Lai C.Y.","year":"2021","unstructured":"Lai C.Y.; Yeh K.Y.; Liu B.F.; Chang T.M.; Chang C.H.; Liao Y.F.; Liu Y.W.; Her G.M.; MicroRNA-21 plays multiple oncometabolic roles in colitis-associated carcinoma and colorectal cancer via the PI3K\/AKT, STAT3, and PDCD4\/TNF-\u03b1 signaling pathways in zebrafish. Cancers 2021,13(21),5565","journal-title":"Cancers"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1053\/j.gastro.2016.11.018","volume":"152","author":"Yang Y.","year":"2017","unstructured":"Yang Y.; Weng W.; Peng J.; Hong L.; Yang L.; Toiyama Y.; Gao R.; Liu M.; Yin M.; Pan C.; Li H.; Guo B.; Zhu Q.; Wei Q.; Moyer M.P.; Wang P.; Cai S.; Goel A.; Qin H.; Ma Y.; Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating toll-like receptor 4 signaling to nuclear factor\u2212\u03baB, and up-regulating expression of microRNA-21. Gastroenterology 2017,152(4),851-866.e24","journal-title":"Gastroenterology"}],"container-title":["Combinatorial Chemistry &amp; High Throughput Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1386207326666230109143325","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/212455\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1386207326666230109143325","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T09:46:35Z","timestamp":1698659195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/212455\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1386207326666230109143325","relation":{},"ISSN":["1386-2073"],"issn-type":[{"value":"1386-2073","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-09-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}